Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
European Heart Journal|August 13, 2014
The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodellingAnne-Christine Ruwald, Valentina Kutyifa, Martin H Ruwald, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 16, 2024
Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastasesSoichiro Yoshida, Yuya Maezawa, Kensaku Ishihara, et al.
Clinical Genitourinary Cancer|January 28, 2025
Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Comprehensive Treatment Outcomes and Prognostic Insights From a Multicenter Real-World Study (YUSHIMA Study)Yuki Nakamura, Hajime Tanaka, Noboru Numao, et al.
The Journal of Clinical Investigation|February 26, 2013
Smap1 deficiency perturbs receptor trafficking and predisposes mice to myelodysplasiaShunsuke Kon, Naoko Minegishi, Kenji Tanabe, et al.
International Journal of Clinical Oncology|April 21, 2025
Prognostic factors and effect of existing predictive models in oligo-metastatic urothelial carcinoma (YUSHIMA study)Kenji Tanabe, Soichiro Yoshida, Tomoki Kimura, et al.
International Journal of Clinical Oncology|June 4, 2024
Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA studyKenji Tanabe, Shuichiro Kobayashi, Yuya Maezawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 4, 2025
Real-World Outcomes of First-Line Systematic Treatment in Locally Advanced or Metastatic Upper Urinary Tract Urothelial Carcinoma With Renal Impairment (YUSHIMA Study)Tomoki Kimura, Motohiro Fujiwara, Yuya Maezawa, et al.
Japanese Journal of Clinical Oncology|March 16, 2026
Lymph node metastasis as a favorable prognostic factor in metastatic urothelial carcinoma with histological variants treated with pembrolizumab: a retrospective multicentric study (YUSHIMA study-04)Ichiro Yonese, Fumitaka Koga, Masahiro Toide, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 22, 2025
Clinical Features and Risk Factors of Enfortumab Vedotin-Induced Peripheral Neuropathy in Patients With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study (YUSHIMA Study)Takahiko Soma, Hajime Tanaka, Yuki Nakamura, et al.
Molecular Biology of the Cell|July 19, 2013
The Arf GAP SMAP2 is necessary for organized vesicle budding from the trans-Golgi network and subsequent acrosome formation in spermiogenesisTomo Funaki, Shunsuke Kon, Kenji Tanabe, et al.
Pageof 10